Malmö University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Diabetes type 2 prevalence is rising among young residents in Malmö, Sweden.
Malmö University, Faculty of Health and Society (HS), Department of Care Science (VV).ORCID iD: 0000-0003-4395-2522
Malmö University, Faculty of Health and Society (HS), Department of Care Science (VV).ORCID iD: 0000-0003-1235-620X
Novo Nordisk Scandinavia AB, Carlsgatan 3, Malmö 211 20, Sweden.
Avdelningen för analys och hållbarhet, Enheten för Statistik och Analys, Stadskontoret, Malmö stad August Palms plats 1, Malmö 205 80, Sweden.
Show others and affiliations
2024 (English)In: Primary Care Diabetes, ISSN 1751-9918, E-ISSN 1878-0210, Vol. 18, no 4, p. 409-413, article id S1751-9918(24)00119-0Article in journal (Refereed) Published
Abstract [en]

Aim: Type 2 diabetes is becoming more prevalent in many parts of the world. Malmö's population has increased in recent years mainly because of migration from other parts of Sweden and the world in addition to increased birth rates. We aimed to explore diabetes prevalence in Malmö in 2011-2018 as well as the achieved treatment targets for selected diabetes-related outcomes.

Method: The current study is a part of the Cities Changing Diabetes Malmö project. Prevalence data were retrieved from the region's primary care and hospital diagnosis register, and data on treatment targets were collected from the National Diabetes Register. The inclusion criteria were either being a resident of Malmö or using a primary healthcare centre located in Malmö.

Results: The prevalence of type 2 diabetes in 2018 doubled from 2011 in the entire Malmö population. During the same period, the prevalence of type 1 diabetes remained stable at 0.49 %. In 2011, the type 2 diabetes prevalence was 2.46 % (2.76 % for males and 2.28 % for females), and in 2018, it was 4.26 % (4.84 % for males and 3.82 % for females). The increase was 139 % for residents aged 0-29 years, 119.6 % for residents aged 30-39 years, 96.2 % for residents aged 40-49 years, 102 % for residents aged 50-59 years, 98.2 % for residents aged 60-69 years, and 115.5 % for those aged 70-79 years. Finally, the increase was 60.9 % for those aged 80-84 years and 90.7 % for residents 90 years of age and older. The National Diabetes Register reported that during 2019, 58 % of all patients with diabetes using primary care in Malmö reached HbA1c <52 mmol/mol, 20 % had albuminuria, 36 % had retinopathy, and 21 % had not had their feet inspected by a healthcare professional during the last year. The median HbA1c was 52.6 mmol/mol, and 17 % were registered as active smokers.

Conclusion: Diabetes prevalence in Malmö has increased markedly in recent years, exacerbated by a rise in type 2 diabetes mainly in the younger population. Targets regarding p-glucose lowering treatments were not met by 42 %. One patient out of three had microvascular complications in the eye, one out of five had impaired kidney function, one out of five had not had their feet inspected, and one out of five was an active smoker. Active diabetes treatments need to be improved to reduce the number of younger patients developing microvascular complications. Preventive activities need to target younger populations to counteract even more residents developing type 2 diabetes.

Place, publisher, year, edition, pages
Elsevier, 2024. Vol. 18, no 4, p. 409-413, article id S1751-9918(24)00119-0
Keywords [en]
Diabetes Complications, Diabetes Mellitus, Epidemiology, Home Care, Migration, National Diabetes Register, Outcome, Prevalence, Prevention, Primary Care
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:mau:diva-70056DOI: 10.1016/j.pcd.2024.06.005ISI: 001284700500001PubMedID: 38839494Scopus ID: 2-s2.0-85195032805OAI: oai:DiVA.org:mau-70056DiVA, id: diva2:1886564
Available from: 2024-08-02 Created: 2024-08-02 Last updated: 2024-08-19Bibliographically approved

Open Access in DiVA

fulltext(499 kB)60 downloads
File information
File name FULLTEXT01.pdfFile size 499 kBChecksum SHA-512
989490e9dbc23704f23ffe6883206eb2debd9a21b6935f4389e9c4750b8b012571d3addc55b2037bf46ed64fa2e1174ebd3ae92fcb5ff62cd44a809990c5e3ee
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Annersten Gershater, MagdalenaRämgård, MargaretaZdravkovic, Slobodan

Search in DiVA

By author/editor
Annersten Gershater, MagdalenaRämgård, MargaretaZdravkovic, Slobodan
By organisation
Department of Care Science (VV)
In the same journal
Primary Care Diabetes
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 60 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 116 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf